All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

Sanofi stock is surging with a Golden Cross formation and promising Dupixent results. With FDA review and potential approval, investors are excited.

Sanofi announces that it has successfully priced its offering of EUR 1.5 billion of notes across 2 tranches: • €850 million floating rate notes, due March 2027, bearing interest at 3-month Euribor ...

Global commodity trader Cargill plans to add 500 jobs to its global capability centres (GCCs) in the next two to three years, ...

Sanofi Indias standalone net profit jumped 31% Rs 91.3 crore in Q4 FY25 as compared with Rs 69.7 crore in Q4 FY24. Revenue increased 9.7% YoY to Rs 514.9 crore in Q4 FY25. Schaeffler Indias ...

Novavax on Thursday posted a narrower fourth-quarter loss and said it expects its licensing deal with French drugmaker Sanofi ...

Sanofi’s Sarclisa has received approval in more than 50 nations and regions. Credit: LCV/Shutterstock. Sanofi’s Sarclisa (isatuximab) has gained approval from Japan’s Ministry of Health, Labour and ...

Earlier in her career, she was an Associate Principal at McKinsey & Company ... Prior to his time at Intercept, Mr. Durso spent over two decades at Sanofi, where he held multiple senior leadership ...

Sanofi and Te­va’s in­flam­ma­to­ry bow­el dis­ease can­di­date could make €1 bil­lion ($1.05 bil­lion) a year by 2032, Leerink an­a­lysts said on Sun­day. The block­buster pro ...

FDA’s Priority Tag to SNY’s Dupixent sBLA for Bullous Pemphigoid Sanofi and Regeneron announced that the FDA has accepted and granted priority review to an sBLA seeking approval of Dupixent ...

Gain valuable work experience at companies or organizations in your career field, Work in one of NYC’s cornerstone industries, Meet students from all over CUNY with similar interests as you, And earn ...

The Bpifrance stake is part of a guarantee from the French Government to keep jobs and production in the country. Sanofi honing its focus on innovative medicines and vaccines while shedding its ...